Toshiba's MR Interface Receives FDA Clearance

Article

Toshiba American Systems Inc. today announced FDA clearance of their M-Power interface aimed at increasing MR exam efficiency. The customizable user interface enables technologists to streamline and accelerate the imaging process and enhance diagnosis, according to the company.

Toshiba American Systems Inc. today announced FDA clearance of their M-Power interface aimed at increasing MR exam efficiency. The customizable user interface enables technologists to streamline and accelerate the imaging process and enhance diagnosis, according to the company.

M-Power will be available for use on Toshiba’s Vantage Atlas, Vantage Titan 1.5 and Titan 3T MR systems with the ability to upgrade already-installed systems.

M-Power reduces the steps to start a procedure, and the interface is designed to enhance and personalize work flow. The Atlas Compass software automates coil selection and turns on the proper coil elements needed for an exam. Finally, mVOX, a volume imaging acquisition sequence available for neuro and orthopedic applications, allows the acquisition of all 3D imaging to be acquired at the same time, according to the company.

“M-Power makes Toshiba’s sophisticated suite of MR software easy to learn and use, allowing technologists of every skill level to access the system’s full range of functionality,” Stuart Clarkson, director, MR Business Unit, Toshiba, said in the company release. “MR technologists are now able to design their own protocols and easily access mTools for greater convenience and productivity.”

 

 

 

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.